Graham Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.5M | Buy |
19,192
+4,259
| +29% | +$333K | 0.02% | 410 |
|
2025
Q1 | $1.08M | Buy |
+14,933
| New | +$1.08M | 0.02% | 502 |
|
2024
Q4 | – | Sell |
-3,061
| Closed | -$202K | – | 1275 |
|
2024
Q3 | $202K | Buy |
+3,061
| New | +$202K | ﹤0.01% | 878 |
|
2023
Q4 | – | Sell |
-2,924
| Closed | -$203K | – | 1063 |
|
2023
Q3 | $203K | Sell |
2,924
-5,081
| -63% | -$352K | ﹤0.01% | 840 |
|
2023
Q2 | $755K | Buy |
+8,005
| New | +$755K | 0.02% | 427 |
|
2023
Q1 | – | Sell |
-12,732
| Closed | -$950K | – | 1122 |
|
2022
Q4 | $950K | Sell |
12,732
-1,506
| -11% | -$112K | 0.03% | 544 |
|
2022
Q3 | $1.18M | Buy |
+14,238
| New | +$1.18M | 0.05% | 406 |
|